{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:27:07Z","timestamp":1789669627923,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00535-013-0821-2","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T01:07:40Z","timestamp":1371604060000},"page":"538-546","source":"Crossref","is-referenced-by-count":35,"title":["Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up"],"prefix":"10.1007","volume":"49","author":[{"given":"Mariko","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM. Hepatitis B virus infection\u2014natural history and clinical consequences. N Engl J Med. 2004;350:1118\u201329.","journal-title":"N Engl J Med"},{"key":"821_CR2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","volume":"337","author":"WM Lee","year":"1997","unstructured":"Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733\u201345.","journal-title":"N Engl J Med"},{"key":"821_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA"},{"key":"821_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.510280130","volume":"28","author":"TI Huo","year":"1998","unstructured":"Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology. 1998;28:231\u20136.","journal-title":"Hepatology"},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678\u201386.","journal-title":"Gastroenterology"},{"key":"821_CR6","doi-asserted-by":"crossref","unstructured":"Arase Y, Ikeda K, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med. 2006;119:71.e9\u201316.","DOI":"10.1016\/j.amjmed.2005.02.033"},{"key":"821_CR7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/gast.2002.36026","volume":"123","author":"YC Chen","year":"2002","unstructured":"Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology. 2002;123:1084\u20139.","journal-title":"Gastroenterology"},{"key":"821_CR8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.21612","volume":"45","author":"CM Chu","year":"2007","unstructured":"Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007;45:1187\u201392.","journal-title":"Hepatology"},{"key":"821_CR9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/j.gastro.2008.07.008","volume":"135","author":"MF Yuen","year":"2008","unstructured":"Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008;135:1192\u20139.","journal-title":"Gastroenterology"},{"key":"821_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00535-012-0548-5","volume":"47","author":"F Suzuki","year":"2012","unstructured":"Suzuki F, Arase Y, Suzuki Y, Akuta N, Sezaki H, Seko Y, et al. Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan. J Gastroenterol. 2012;47:814\u201322.","journal-title":"J Gastroenterol"},{"key":"821_CR11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jmv.20994","volume":"79","author":"M Kobayashi","year":"2007","unstructured":"Kobayashi M, Suzuki F, Akuta N, Hosaka T, Sezaki H, Yatsuji H, et al. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine. J Med Virol. 2007;79:1472\u20137.","journal-title":"J Med Virol"},{"key":"821_CR12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.20305","volume":"75","author":"N Akuta","year":"2005","unstructured":"Akuta N, Suzuki F, Suzuki Y, Sezaki H, Hosaka T, Someya T, et al. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study. J Med Virol. 2005;75:491\u20138.","journal-title":"J Med Virol"},{"key":"821_CR13","doi-asserted-by":"crossref","unstructured":"Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, et al. Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study. J Gastroenterol. 2012. doi: 10.1007\/s00535-012-0688-7 .","DOI":"10.1007\/s00535-012-0688-7"},{"key":"821_CR14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhep.2004.10.026","volume":"42","author":"SH Ahn","year":"2005","unstructured":"Ahn SH, Park YN, Park JY, Chang HY, Lee JM, Shin JE, et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol. 2005;42:188\u201394.","journal-title":"J Hepatol"},{"key":"821_CR15","unstructured":"Kim JH, Lee JH, Park SJ, Bae MH, Kim JH, Kim do Y, et al. Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study. Hepatogastroenterology. 2008;55:578\u201381."},{"key":"821_CR16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","volume":"2","author":"YF Liaw","year":"2008","unstructured":"Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008;2:263\u201383.","journal-title":"Hepatol Int"},{"key":"821_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.gastro.2010.04.048","volume":"139","author":"J Liu","year":"2010","unstructured":"Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology. 2010;139:474\u201382.","journal-title":"Gastroenterology"},{"key":"821_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s005350050331","volume":"35","author":"Y Kato","year":"2000","unstructured":"Kato Y, Nakao K, Hamasaki K, Kato H, Nakata K, Kusumoto Y, et al. Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan. J Gastroenterol. 2000;35:201\u20135.","journal-title":"J Gastroenterol"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-135-9-200111060-00006","volume":"135","author":"BJ McMahon","year":"2001","unstructured":"McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135:759\u201368.","journal-title":"Ann Intern Med"},{"key":"821_CR20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.23464","volume":"51","author":"J Simonetti","year":"2010","unstructured":"Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology. 2010;51:1531\u20137.","journal-title":"Hepatology"},{"key":"821_CR21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3476(80)80261-7","volume":"97","author":"K Shiraki","year":"1980","unstructured":"Shiraki K, Yoshihara N, Sakurai M, Eto T, Kawana T. Acute hepatitis B in infants born to carrier mothers with the antibody to hepatitis B e antigen. J Pediatr. 1980;97:768\u201370.","journal-title":"J Pediatr"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0821-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-013-0821-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-013-0821-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T17:21:34Z","timestamp":1563211294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-013-0821-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s00535-013-0821-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}